Protective effects of psychiatric medications against COVID-19 mortality before vaccines.
The coronavirus disease pandemic caused by the coronavirus SARS-CoV-2, which emerged in the United States in late 2019 to early 2020 and quickly escalated into a national public health crisis. Research has identified psychiatric conditions as possible risk factors associated with COVID-19 infection...
Saved in:
| Main Authors: | Rodrigo Machado-Vieira, Trudy M Krause, Gregory Jones, Antonio L Teixeira, Lokesh R Shahani, Scott D Lane, Jair C Soares, Chau N Truong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0310438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 mortality among solid organ transplant recipients and candidates before specific vaccine availability in Colombia
by: Yazmin R Arias-Murillo, et al.
Published: (2024-12-01) -
Prevalence of COVID-19 among healthcare workers before and after vaccination
by: Karina Pinheiro Teixeira dos Reis, et al.
Published: (2025-01-01) -
Psychiatric disorders in myasthenia gravis
by: Mariana Inés Ybarra, et al.
Published: (2011-04-01) -
Psychiatric neuroimaging at a crossroads: Insights from psychiatric genetics
by: Lorenza Dall’Aglio, et al.
Published: (2024-12-01) -
Mortality rate in patients in a long-term psychiatric care facility in Johannesburg
by: Mokgokong Mathekga, et al.
Published: (2024-11-01)